| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT06091943 Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in… |
Trial completed |
| 2026-08-11 | NCT07169331 A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With… |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT07169331 A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With… |
Enrollment reduced: 18 -> 16 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07169331 | A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With… | Waldenström's Macroglobulinemia | Active, Not Recruiting |
| Phase 3 | |||
| NCT04170283 | Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell… | B-cell Malignancies | Active, Not Recruiting |
| NCT03336333 | A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT03519230 | Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive… | Ovarian Cancer | Active, Not Recruiting |
| NCT04379635 | Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT03967977 | Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for… | Urothelial Carcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT03736889 | Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR… | MSI-H/dMMR Solid Tumors | Recruiting |
| NCT05479994 | Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic… | Leukemia | Active, Not Recruiting |
| NCT05635708 | A Study of Tislelizumab in Combination With Investigational Agents in Participants With… | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT05909904 | A Study of Tislelizumab in Combination With Investigational Agents in Participants With… | Head and Neck Squamous Cell Carcinoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05294731 | Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton… | B-cell Malignancy | Recruiting |
| NCT05471843 | Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell… | Mantle Cell Lymphoma | Active, Not Recruiting |
| NCT05661955 | A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics… | Urothelial Carcinoma | Active, Not Recruiting |
| NCT05609370 | A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab… | Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT06257264 | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With… | Breast Cancer | Active, Not Recruiting |
| NCT04883957 | Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies | Mature B-cell Malignancies | Active, Not Recruiting |
| Not specified | |||
| NCT05640102 | Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants… | Waldenstrom Macroglobulinemia | Recruiting |